臨床検査部
研究業績
  1. Aiba T, Ohno S, Takegami M, Kato Y, Sakaguchi H, Shimamoto K, Sonoda K, Ida K, Sumitomo N, Nabeshima T, Murakami T, Ninomiya Y, Kato K, Fukuyama M, Makiyama T, Hayashi K, Ohta K, Morita H, Nakajima T, Kaneko Y, Yagihara N, Otsuki S, Kosho T, Yoshida Y, Takamuro M, Ueno M, Takahashi T, Inden Y, Hayabuchi Y, Muraji S, Watanabe S, Nishimura K, Asano Y, Horigome H, Yoshinaga M, Horie M, Shimizu W, Kusano K. Clinical Impact of Genetic Testing for Long QT Syndrome ― Evidence From a Nationwide LQTS Registry in Japan ―. Circulation Journal. 89, 835-844, 2025.
  2. Ikee T, Nakajima K, Ishibashi K, Tateishi E, Tonegawa-Kuji R, Nakamura T, Oka S, Miyazaki Y, Wakamiya A, Ueda N, Kamakura T, Wada M, Inoue Y, Miyamoto K, Nagase S, Aiba T, Fukuda T, Kusano K. Prevalence of ventricular parasystole in patients with cardiac sarcoidosis: correlation between parasystole and inflammation in ventricular fibrillation. Open Heart. 12, e003196, 2025.
  3. Ishiwata M, Kanaoka K, Tonegawa-Kuji R, Sumita Y, Nakamura T, Oka S, Miyazaki Y, Wakamiya A, Ueda N, Nakajima K, Kamakura T, Wada M, Ishibashi K, Inoue Y, Miyamoto K, Kusano K, Aiba T. Timing of Catheter Ablation for Ventricular Tachycardia and Prognosis After Emergent Hospitalization - Results From the JROAD-DPC Database. Circulation Reports. 7, 756-763, 2025.
  4. Ishiwata M, Ueda N, Ishibashi K, Nakamura T, Oka S, Miyazaki Y, Wakamiya A, Nakajima K, Kamakura T, Wada M, Inoue Y, Miyamoto K, Nagase S, Aiba T, Kitai T, Izumi C, Noguchi T, Kusano K. SMART Pass automatic deactivation of subcutaneous implantable cardioverter-defibrillators. Heart Rhythm. 22, 1255-1263, 2025.
  5. Ishiwata M, Ishibashi K, Kato Y, Sakaguchi H, Nakamura T, Oka S, Miyazaki Y, Wakamiya A, Ueda N, Nakajima K, Kamakura T, Wada M, Inoue Y, Miyamoto K, Aiba T, Takeda N, Kusano K. Long-Term Outcome of Adult Congenital Heart Disease Patients with Implantable Cardioverter-Defibrillators. Congenital Heart Disease. 20, 273-286, 2025.
  6. Kamoshida J, Ishibashi K, Kawabata T, Enokizono K, Oka S, Miyazaki Y, Shimamoto K, Wakamiya A, Ueda N, Nakajima K, Kamakura T, Wada M, Inoue Y, Miyamoto K, Nagase S, Aiba T, Kusano K. Usefulness of Additional ECG Indicators for Prognosis Prediction in Patients With Cardiac Sarcoidosis. JACC: Clinical Electrophysiology. 11, 2365-2375, 2025.
  7. Kawase K, Ueda N, Ishibashi K, Nakamura T, Oka S, Miyazaki Y, Wakamiya A, Nakajima K, Kamakura T, Wada M, Inoue Y, Miyamoto K, Aiba T, Kusano K. Efficacy of a novel compression tool in preventing complications following device implantation. Open Heart. 12, e003613, 2025.
  8. Matsuura H, Kamakura T, Oshima T, Nakamura T, Oka S, Miyazaki Y, Wakamiya A, Ueda N, Nakajima K, Wada M, Ishibashi K, Inoue Y, Miyamoto K, Aiba T, Kusano K. Incidence and Characteristics of Superior Vena Cava Impact After Pulsed-Field Ablation of the Right Pulmonary Veins. Journal of Cardiovascular Electrophysiology. 36, 1948-1956, 2025.
  9. Miyamoto K, Kanaoka K, Yodogawa K, Fujimoto Y, Fukunaga H, Asano S, Nagase T, Terasawa M, Kusume T, Takada Y, Takarada K, Sagawa Y, Shigeta T, Ooka J, Ishikura M, Yoh M, Takahashi H, Inoue Y, Nagase S, Aiba T, Kataoka N, Takagi M, Yamagami S, Nishiuchi S, Sasaki Y, Kobori A, Yamauchi Y, Yazaki Y, Satomi K, Nitta J, Mizuno S, Murakami M, Ashikaga K, Kishihara J, Fukaya H, Iwasaki YK, Shimizu W, Kusano K. Cryoballoon vs radiofrequency ablation in persistent atrial fibrillation: the CRRF-PeAF trial. European Heart Journal. 46, 4426-4437, 2025.
  10. Miyazaki Y, Ishibashi K, Ueda N, Nakamura T, Oka S, Wakamiya A, Nakajima K, Kamakura T, Wada M, Inoue Y, Miyamoto K, Nagase S, Aiba T, Kusano K. Mid-Range Paced-QRS as an Independent Negative Predictor of Cardiac Events ― Right Ventricular Pacing Implications ―. Circulation Journal. 89, 803-808, 2025.
  11. Nakamura T, Ishibashi K, Useda N, Oka S, Miyazaki Y, Wakamiya A, Nakajima K, Kamakura T, Wada M, Inoue Y, Miyamoto K, Nagase S, Aiba T, Kusano K. Identifying non-responders to cardiac resynchronization therapy in the non-left bundle branch block. Journal of Interventional Cardiac Electrophysiology. 68, 701-708, 2025.
  12. Nakatsuji K, Otsuki S, Kamakura T, Oshima T, Nakamura T, Oka S, Miyazaki Y, Wakamiya A, Ueda N, Nakajima K, Wada M, Ishibashi K, Inoue Y, Miyamoto K, Aiba T, Kusano K. Long-term outcomes of atrial antitachycardia pacing to prevent progression to permanent atrial fibrillation in patients implanted with pacemakers. Heart Rhythm O2. 6, 960-968, 2025.
  13. Oshima T, Ishibashi K, Yamagata K, Ueda N, Nakamura T, Oka S, Miyazaki Y, Wakamiya A, Nakajima K, Shimizu Y, Watanabe T, Kamakura T, Wada M, Ishida J, Inoue Y, Miyamoto K, Amiya E, Fujiu K, Hatano M, Tsukamoto Y, Aiba T, Fukushima S, Takeda N, Ono M, Kusano K. Long-Term Implantable Cardioverter Defibrillator Lead Dysfunction After Left Ventricular Assist Device Implantation. JACC: Advances. 4, 102258, 2025.
  14. Shako D, Nagase S, Kataoka N, Nakamura T, Oka S, Miyazaki Y, Wakamiya A, Nakajima K, Ueda N, Kamakura T, Wada M, Ishibashi K, Inoue Y, Miyamoto K, Aiba T, Kusano K. Automated Assessment to Predict Lethal Arrhythmias in Brugada Syndrome: Significance of R' in Lead III. Journal of Arrhythmia. 41, e70166, 2025.
  15. Ueda N, Ishibashi K, Noda T, Oka S, Miyazaki Y, Wakamiya A, Nakajima K, Kamakura T, Wada M, Inoue Y, Miyamoto K, Nagase S, Aiba T, Kanzaki H, Izumi C, Noguchi T, Kusano K. Ventricular Arrhythmia Risk Stratification Among Patients With Cardiac Resynchronization Therapy Devices. Circulation Reports. 7, 861-868, 2025.
  16. Ueda N, Oka S, Ishibashi K, Oshima T, Nakamura T, Miyazaki Y, Wakamiya A, Nakajima K, Kamakura T, Wada M, Inoue Y, Miyamoto K, Aiba T, Kanzaki H, Izumi C, Noguchi T, Kusano K. Optimization of pacing for patients receiving ineffective cardiac resynchronization therapy. Heart Rhythm. 23, e15-e24, 2025.
  17. Uehara Y, Ueda N, Mori S, Kawabata T, Ishibashi K, Oshima T, Nakamura T, Oka S, Miyazaki Y, Wakamiya A, Nakajima K, Kamakura T, Wada M, Inoue Y, Miyamoto K, Aiba T, Kusano K. Significance of 3-dimensional cardiac anatomical axis as the predictor of low QRS amplitude of subcutaneous implantable cardioverter-defibrillator. Heart Rhythm O2. 6, 1743-1751, 2025.
  18. Zaizen T, Kondo H, Noguchi T, Tonegawa-Kuji R, Kamakura T, Wada M, Ishibashi K, Inoue Y, Miyamoto K, Aiba T, Takahashi N, Kusano K. Low Body Mass Index as a Predictor of Amiodarone-Induced Pulmonary Toxicity. Journal of Arrhythmia. 41, e70205, 2025.
  19. Oshima Y, Ueda N, Ishibashi K, Nakamura T, Oka S, Wakamiya A, Nakajima K, Kamakura T, Wada M, Inoue Y, Miyamoto K, Nagase S, Aiba T, Kusano K. Long-term outcomes of upgrading to cardiac resynchronization therapy in patients with left bundle branch block or right ventricular pacing. Heart Rhythm O2. 6, 1960-1967, 2025.
  20. Imai Y, Kusano K, Aiba T, Ako J, Asano Y, Harada-Shiba M, Kataoka M, Kosho T, Kubo T, Matsumura T, Minamino T, Minatoya K, Morita H, Nishigaki M, Nomura S, Ogino H, Ohno S, Takamura M, Tanaka T, Tsujita K, Uchida T, Yamagishi H, Ebana Y, Fujita K, Ida K, Inoue S, Ito K, Kuramoto Y, Maeda J, Matsunaga K, Neki R, Sugiura K, Tada H, Tsuji A, Yamada T, Yamaguchi T, Yamamoto E, Kimura A, Kuwahara K, Maemura K, Minamino T, Morisaki H, Tokunaga K; Japanese Circulation Society; Japanese College of Cardiology; Japanese Society of Pediatric Cardiology; Cardiac Surgery Joint Working Group. JCS/JCC/JSPCCS 2024 Guideline on Genetic Testing and Counseling in Cardiovascular Disease. Journal of Cardiology. 85, 115-176, 2025.
  21. 相庭 武司. 先天性QT延長症候群の最新知見とエビデンス 日本における多施設登録研究から. 小児科. 66, 506-514, 2025.
  22. 相庭 武司. 遺伝性不整脈に対する遺伝学的検査の臨床的意義. 遺伝子医学. 15, 48-55, 2025.
  23. 相庭 武司. 心房細動のメカニズムを遺伝的素因から考える. Heart View. 29, 744-749, 2025.
  24. 相庭 武司. 不整脈疾患に対する遺伝学的検査. 日本臨床 増刊号1 不整脈診療学. 83, 115-120, 2025.
  25. 相庭 武司. 房室ブロック. 今日の治療指針 2025年版. 394-396, 2025.